ISRG · Intuitive Surgical Inc
Price
Snapshot
50 fields · last close| Market Cap | $150.7B |
| P/E | 48.03 |
| Float | 351.1M |
| Beta | 1.45 |
| Volatility | 36.3% |
| Exchange | NASDAQ |
| Sector | Health Care |
| Cap tier | Large cap |
| Macro sensitivity | High |
| Clavix score | 70.6 |
| Price | 432.33 |
| Change | +1.32% |
| Prev Close | 426.70 |
| Open | 428.43 |
| Day Low | 425.51 |
| Day High | 434.89 |
| Avg Vol | 2 |
| Avg $ Vol | $829.8M |
| 52W High | 603.88 |
| 52W Low | 328.57 |
| 52W Pos | 37.7% |
| From High | −28.41% |
| From Low | +31.58% |
| Max DD 1Y | −44.00% |
| Spread | 0.10% |
| Liquidity | Deep |
| SMA 20 | +5.15% |
| SMA 50 | +10.38% |
| SMA 200 | −1.66% |
| RSI (14) | 64.7 |
| Vol 30D | 28.2% |
| Vol 90D | 43.3% |
| 1Y Range | 329–604 |
| Daily bars | 536 |
| Perf Week | +0.65% |
| Perf Month | +11.25% |
| Perf Quarter | +20.82% |
| Perf Half Y | −9.06% |
| Perf Year | −2.05% |
| Perf YTD | −23.07% |
| Prev Day | +1.32% |
| Clavix | B- |
| Debt / Eq | 0.00 |
| Curr Ratio | 4.87 |
| Int Cover | — |
| FCF Margin | 30.1% |
| Rev Growth | +20.5% |
| Profit | Profitable |
| Leverage | Low |
| Sector rank | 41 / 49 |
What ISRG does
Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally.
It offers the da Vinci Surgical System that enables surgical procedures using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic endoluminal procedures enabling minimally invasive biopsies in the lung.
The company also provides a suite of stapling, energy, and core instrumentation for its multi-port da Vinci surgical systems; progressive learning pathways to support the use of its technology; infrastructure of customer service and support specialists, a complement of services to its customers, including installation, repair, maintenance, 24/7 technical support, and proactive system health monitoring; and integrated digital capabilities providing connected offerings, streamlining performance for hospitals with program-enhancing insights.
It sells its products through direct sales organizations, such as capital and clinical sales teams. Intuitive Surgical, Inc. was incorporated in 1995 and is headquartered in Sunnyvale, California.
Clavix risk grade
regraded every trading dayISRG grades B-, 70.6 of 100. Steadiest on Sector Resilience (63), most exposed on News Sentiment (53, mixed). 0 of the 4 weighted dimensions sit above the Health Care median. Ranks 41 of 49 in Health Care by Clavix score.
How rough the ride is
| ISRG | Health Care median | |
|---|---|---|
| Betavs the overall market · lower is steadier | 1.45 | 0.84 |
| Volatilityannualized | 36.3% | 20.9% |
| Max drawdown, past yearworst peak-to-trough fall | −44.0% | — |
| Typical daily movemedian absolute daily change | 1.17% | — |
| Days beyond ±3%of the last 252 sessions | 25 (10%) | — |
How its days are spread
Daily returns over the last 252 sessions in 1% bins. Moves beyond ±6% land in the end bins.
52-week range
The bar runs from the lowest to the highest close of the last 252 sessions; the marker is the latest close.
Drawdown from the 1-year peak
Percent below the running high over the last 12 months. Zero is a fresh high.
Market sensitivity
| ISRG | Health Care median | |
|---|---|---|
| Beta to the markethow much it swings with the S&P 500 · lower is safer | 1.45 | 0.84 |
| Macro sensitivityrate, dollar and credit exposure bucket | High | Moderate 53% of 49 |
Where it sits on the macro scale
Low means rates, the dollar and credit spreads barely move it. Very High means they drive a large share of its swings. The counts are how many Health Care names sit in each bucket.
Where it ranks in its sector
Rank by Clavix score within the sector. Right is the top of the sector.
Price performance
| ISRG | |
|---|---|
| 1 week | +0.6% |
| 1 month | +11.3% |
| Year to date | −23.1% |
| 1 year | −2.0% |
Context for the rank, not itself a risk measure.
Recent coverage, scored
| ISRG | |
|---|---|
| Articles scoredthe most recent scored coverage, up to 30 | 30 since 14 Sep |
| Average score0 most bearish, 100 most bullish | 59 |
| Bullish · bearisharticles above 60 · below 40 | 18 · 6 |
| Directionarticles whose tone is improving vs worsening | 18 ↑ 6 ↓ |
Where the article scores land
Each bar is a 10-point band of article scores. Below 40 reads bearish, above 60 bullish.
Balance sheet, against the sector
The shaded band is the middle half of the 49 Health Care names Clavix covers; the tick is the sector median.
Growth
| ISRG | |
|---|---|
| Revenue growthyear over year | +20.5% |
Financial Health is shown but does not count toward the grade. Why
0–100, higher is safer. The tick on each bar is the Health Care median. Click a dimension for the evidence behind it. Financial Health is shown but does not count toward the grade.
Recent news
most recent scored articles · the chip is the article’s score · click to openAn analysis piece questioning whether Intuitive Surgical's (ISRG) stock is fairly valued at US$427.86 given that it has risen 56.5% over the past three years, with a new competitor now entering the field after Johnson & Johnson's OTTAVA robotic surgery system received FDA clearance.
Asset manager Assenagon Asset Management S.A. raised its stake in Intuitive Surgical by 55.8% during the third quarter, ending the period with 1,557,940 shares according to its SEC Form 13F filing. The article is truncated and does not include further details.
Intuitive Surgical has sent a new robotic endoscope to the FDA for review, aimed at gastrointestinal (GI) care. The device could open a new growth area for the company beyond its core surgical robotics business.
Intuitive Surgical submitted a next-generation robotic endoscope to the FDA for use in gastrointestinal (GI) care, opening a potential new growth area beyond its core surgical robotics business.
Barclays issued a research note on Wednesday upgrading Intuitive Surgical's stock rating to "strong-buy." The article provides no further detail on the rationale or any company-specific development.
Nearest peers by size
Health Care| Ticker | Company | Grade | Mkt cap | P/E | Beta | |
|---|---|---|---|---|---|---|
| ABT | Abbott Laboratories | B+ | $181.5B | 33.46 | 0.55 | Compare |
| MDT | Medtronic PLC | A- | $121.2B | 23.16 | 0.59 | Compare |
| CVS | CVS Health Corp | A- | $118.1B | 24.16 | 0.58 | Compare |
| MCK | McKesson Corp | B+ | $117.2B | 25.51 | 0.30 | Compare |
| SYK | Stryker Corp | B | $113.0B | 30.31 | 0.79 | Compare |
| HCA | HCA Healthcare Inc | B+ | $99.34B | 14.52 | 1.12 | Compare |
| ELV | Elevance Health Inc | B+ | $92.88B | 18.71 | 0.64 | Compare |
| CI | Cigna Group | A- | $79.88B | 12.45 | 0.25 | Compare |
You just read one holding. Clavix reads the whole portfolio.
Every position you own, graded on the same five dimensions, with an alert when a grade moves. 1 month free on iPhone.